Manchester Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$225K Sell
506
-20
-4% -$8.9K 0.03% 318
2025
Q1
$255K Sell
526
-174
-25% -$84.4K 0.03% 299
2024
Q4
$282K Sell
700
-31
-4% -$12.5K 0.03% 289
2024
Q3
$340K Buy
731
+31
+4% +$14.4K 0.04% 266
2024
Q2
$328K Buy
700
+291
+71% +$136K 0.04% 253
2024
Q1
$171K Sell
409
-16
-4% -$6.69K 0.02% 329
2023
Q4
$173K Buy
425
+230
+118% +$93.6K 0.02% 299
2023
Q3
$67.8K Buy
195
+136
+231% +$47.3K 0.01% 385
2023
Q2
$20.8K Buy
59
+5
+9% +$1.76K ﹤0.01% 496
2023
Q1
$17K Hold
54
﹤0.01% 509
2022
Q4
$15.6K Sell
54
-4
-7% -$1.16K ﹤0.01% 431
2022
Q3
$17K Hold
58
﹤0.01% 415
2022
Q2
$16K Hold
58
﹤0.01% 439
2022
Q1
$15K Hold
58
﹤0.01% 500
2021
Q4
$13K Buy
58
+4
+7% +$897 ﹤0.01% 537
2021
Q3
$10K Hold
54
﹤0.01% 594
2021
Q2
$11K Hold
54
﹤0.01% 492
2021
Q1
$12K Hold
54
﹤0.01% 473
2020
Q4
$13K Sell
54
-4
-7% -$963 ﹤0.01% 463
2020
Q3
$16K Buy
58
+4
+7% +$1.1K ﹤0.01% 394
2020
Q2
$16K Hold
54
﹤0.01% 438
2020
Q1
$13K Hold
54
﹤0.01% 449
2019
Q4
$12K Hold
54
﹤0.01% 458
2019
Q3
$9K Hold
54
﹤0.01% 464
2019
Q2
$10K Hold
54
﹤0.01% 486
2019
Q1
$10K Buy
+54
New +$10K ﹤0.01% 564
2015
Q1
Sell
-134
Closed -$16K 895
2014
Q4
$16K Hold
134
﹤0.01% 917
2014
Q3
$15K Hold
134
﹤0.01% 916
2014
Q2
$13K Buy
134
+94
+235% +$9.12K ﹤0.01% 905
2014
Q1
$3K Sell
40
-14
-26% -$1.05K ﹤0.01% 949
2013
Q4
$4K Buy
54
+11
+26% +$815 ﹤0.01% 861
2013
Q3
$3K Buy
+43
New +$3K ﹤0.01% 933